July 07, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHILADELPHIA — Menopause is an important time to prioritize women’s cardio-kidney-metabolic health, but questions remain about the impact of estrogen and hormone therapy on progression of heart disease, a speaker reported.At the Heart in Diabetes CME Conference, Martha Gulati, MD, MS, FACC, FAHA, FASPC, director of the Davis Women’s Heart Center at Houston Methodist DeBakey
July 07, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

PHILADELPHIA — Women may have higher risk for heart disease related to elevated blood pressure compared with men, yet only one in…

PHILADELPHIA — Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that…

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM,…

CHICAGO — In postmenopausal women, use of menopausal hormone therapy was associated with higher bone mineral density compared…

NORTHAMPTON, MA / ACCESS Newswire / July 1, 2026 / CVS HealthOriginally published on CVS Health Company NewsroomDr. Joanne…

PARK CITY, Utah — Women who are perimenopausal or menopausal have no contraindications to participating in activities at high…